• OPEN AN ACCOUNT
Indian Indices
Nifty
22,402.40 34.40
(0.15%)
Sensex
74,339.44 486.50
( 0.66%)
Bank Nifty
48,189.00 218.55
( 0.46%)
Nifty IT
33,442.55 -272.00
( -0.81%)
Global Indices
Nasdaq
15,712.75 16.11
(0.10%)
Dow Jones
38,460.92 -42.77
(-0.11%)
Hang Seng
17,284.54 83.27
(0.48%)
Nikkei 225
37,628.48 -831.60
(-2.16%)
Forex
USD-INR
83.31 -0.07
(-0.09%)
EUR-INR
88.96 0.13
(0.14%)
GBP-INR
103.28 0.27
(0.26%)
JPY-INR
0.54 0.00
(-0.11%)

EQUITY - MARKET SCREENER

Ishita Drugs & Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524400
INE806D01016
31.8401338
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
33.14
21.41
EPS(TTM)
Face Value()
Div & Yield %
2.16
10
0
 

ntpc ltd
NTPC arm declares commercial operation of last part of Nokhra Solar PV project
Jun 03,2023
The project of NTPC Green Energy was declared on commercial operation with effect from 00:00 hrs of 3 June 2023.

The first part capacity of 100 MW has already been declared on commercial operation with effect from 20 December 2022, second part capacity of 50 MW with effect from 30 December 2022, third part capacity of 50 MW with effect from 16 February 2023 and fourth part capacity of 50 MW with effect from 01 April 2023.

With this, installed and commercial capacity of NTPC Green Energy will become 2711 MW while group installed and commercial capacity of NTPC will become 72354 MW.

NTPC is primarily involved in the generation and sale of bulk power to state power utilities. Other business of the group includes providing consultancy, project management & supervision, energy trading, oil & gas exploration and coal mining. The Government of India holds 51.10% stake in NTPC as of 31 March 2023.

The company recorded 1% rise in standalone net profit to Rs 5,672.32 crore on a 21.8% increase in total income to Rs 43,399.15 crore in Q4 FY23 as compared with Q4 FY22.

The scrip fell 0.06% to settle at Rs 174.20 on Friday, 3 June 2023.